Heart Beat
I wrote this the night suzy and I came back from hearing what would be our son - CMB III's-
heart beat
Heartbeat
for baby b
I heard your heart
and mine stood still
As I
Listen to it beating so
Fast & strong
Smooth
With
Rythem and Vigor
Standing holding
your mothers hand
With tears in my Eyes
Hope filled my existance
As it
seemed to mean
That much
more
Thanks to you and
Your mother
my heart
has a new beat
Thursday, June 18, 2009
Veterans Business Association
Veterans Business Association
The next Veterans Business Association meeting will take place on
June 24th from 6pm-8pm at the Crowne Plaza Hotel at 36 Valley Roadin Clark, NJ.The VBA works in conjunction with the Gateway Regional Chamber ofCommerce to help Veterans network and help those transitioning outof the military.
You may pay at the door, or pay online at:http://gatewaynjcoc.weblinkconnect.com/CWT/External/WCPages/WCEvents/EventDetail.aspx?EventID=515
Our guest speaker for this event is Sandy Schussel of Brass RingCoaching. For the past ten years, Sandy has been speaking, coachingand training individuals and organizations throughout the UnitedStates, helping them learn to attract all of the quality clientsthey want, regardless of economic conditions.Sandy's first book, The High Diving Board: How To Overcome YourFears and Live Your Dreams, acknowledges that one of the greatestbarriers to success for professionals of all types, including salesprofessionals, is fear. He has helped thousands of people take theirfirst steps to a better career or business and a better life. Hisnew book, Become a Client Magnet: 27 Strategies to Boost Your Client-Attraction Factor, is due out this summer.We look forward to hearing ideas about how to grow our businesses.
Semper Fi -
Richard C. Vaill, AVP
Business Development Officer
Richard.Vaill@ProvidentNJ.com
The Provident Bank
250 Madison Avenue
Morristown, NJ 07960
Office: (973) 644-5403
Cell: (973) 699-5616
The next Veterans Business Association meeting will take place on
June 24th from 6pm-8pm at the Crowne Plaza Hotel at 36 Valley Roadin Clark, NJ.The VBA works in conjunction with the Gateway Regional Chamber ofCommerce to help Veterans network and help those transitioning outof the military.
You may pay at the door, or pay online at:http://gatewaynjcoc.weblinkconnect.com/CWT/External/WCPages/WCEvents/EventDetail.aspx?EventID=515
Our guest speaker for this event is Sandy Schussel of Brass RingCoaching. For the past ten years, Sandy has been speaking, coachingand training individuals and organizations throughout the UnitedStates, helping them learn to attract all of the quality clientsthey want, regardless of economic conditions.Sandy's first book, The High Diving Board: How To Overcome YourFears and Live Your Dreams, acknowledges that one of the greatestbarriers to success for professionals of all types, including salesprofessionals, is fear. He has helped thousands of people take theirfirst steps to a better career or business and a better life. Hisnew book, Become a Client Magnet: 27 Strategies to Boost Your Client-Attraction Factor, is due out this summer.We look forward to hearing ideas about how to grow our businesses.
Semper Fi -
Richard C. Vaill, AVP
Business Development Officer
Richard.Vaill@ProvidentNJ.com
The Provident Bank
250 Madison Avenue
Morristown, NJ 07960
Office: (973) 644-5403
Cell: (973) 699-5616
Sorting Through the different types of Breast Cancer
Sorting Through the Different Types of Breast Cancer
http://drktruddy.wordpress.com/
June 8, 2009 by drktruddy
Years ago doctors grouped women with breast cancer into four “stages” depending on three measures: the size of the tumor (T), the number of lymph nodes involved (N) and whether there was any evidence of metastatic disease (M). This was referred to as the TNM Staging System – and it was used to predict prognosis and tailor treatment for the individual patient. It was crude, at best; but it was all there was for many years.
Also during the last century, three other “markers” were discovered that became useful for determining treatment and gauging prognosis. They were: estrogen receptor (ER), progesterone receptor (PR) and Her2-neu. Tamoxifen, and then aromatase inhibitors (e.g., Arimidex), were used to “target” those patients whose tumors expressed ER and/or PR, and then Herceptin was created to treat those women whose tumors expressed Her2-neu.
Although TNM staging remains entrenched for grouping women with breast cancer, much-needed modifications are underway. Breast cancers have now been reclassified into four types, based on the receptors they do, or do not, express:
Luminal A – ER or PR positive, low grade (best prognosis)
Luminal B – ER or PR positive, higher grade (not great prognosis, but not terrible either)
Her 2 - expresses this receptor, associated with more aggressive disease and worse prognosis
Basal - does not express any of the receptors: poor prognosis (although responds well to chemotherapy)
The New Millennium has arrived and with it an entirely new way of understanding the “language” of cancer: this is done by gene array analysis. In short, this is the newest and best way to understand how cancers behave AT THE LEVEL OF THE GENES THEY EXPRESS. Wonderful, except it is very expensive and time-consuming. Good news: researchers have identified an “old-fashioned” laboratory way to distinguish Luminal A from Luminal B tumors (this can be tricky) based on a test called, Ki67. This additional test is a marker for proliferative potential of the tumor, a way of gauging how aggressively it may grow.
Dr. Chang has published a paper in the Journal of the National Cancer Institute that shows that Ki67 levels are a good way to tell a typical Luminal A from a typical Luminal B breast cancer – in addition to the parameters given above: 14% is the cutoff.
If the Ki67 is below 14%, the tumor can be considered Luminal A; if the Ki67 is over 14% then it can be considered a Luminal B.
It is not certain what difference this will make for treatment at the moment. But women, and the physicians who care for them, will have another piece of cost-effective and readily available information that, in the near future, might help design an even better fit between the patient and her treatment.
Chang, JNCI 2009. 101: 736-750
http://drktruddy.wordpress.com/
June 8, 2009 by drktruddy
Years ago doctors grouped women with breast cancer into four “stages” depending on three measures: the size of the tumor (T), the number of lymph nodes involved (N) and whether there was any evidence of metastatic disease (M). This was referred to as the TNM Staging System – and it was used to predict prognosis and tailor treatment for the individual patient. It was crude, at best; but it was all there was for many years.
Also during the last century, three other “markers” were discovered that became useful for determining treatment and gauging prognosis. They were: estrogen receptor (ER), progesterone receptor (PR) and Her2-neu. Tamoxifen, and then aromatase inhibitors (e.g., Arimidex), were used to “target” those patients whose tumors expressed ER and/or PR, and then Herceptin was created to treat those women whose tumors expressed Her2-neu.
Although TNM staging remains entrenched for grouping women with breast cancer, much-needed modifications are underway. Breast cancers have now been reclassified into four types, based on the receptors they do, or do not, express:
Luminal A – ER or PR positive, low grade (best prognosis)
Luminal B – ER or PR positive, higher grade (not great prognosis, but not terrible either)
Her 2 - expresses this receptor, associated with more aggressive disease and worse prognosis
Basal - does not express any of the receptors: poor prognosis (although responds well to chemotherapy)
The New Millennium has arrived and with it an entirely new way of understanding the “language” of cancer: this is done by gene array analysis. In short, this is the newest and best way to understand how cancers behave AT THE LEVEL OF THE GENES THEY EXPRESS. Wonderful, except it is very expensive and time-consuming. Good news: researchers have identified an “old-fashioned” laboratory way to distinguish Luminal A from Luminal B tumors (this can be tricky) based on a test called, Ki67. This additional test is a marker for proliferative potential of the tumor, a way of gauging how aggressively it may grow.
Dr. Chang has published a paper in the Journal of the National Cancer Institute that shows that Ki67 levels are a good way to tell a typical Luminal A from a typical Luminal B breast cancer – in addition to the parameters given above: 14% is the cutoff.
If the Ki67 is below 14%, the tumor can be considered Luminal A; if the Ki67 is over 14% then it can be considered a Luminal B.
It is not certain what difference this will make for treatment at the moment. But women, and the physicians who care for them, will have another piece of cost-effective and readily available information that, in the near future, might help design an even better fit between the patient and her treatment.
Chang, JNCI 2009. 101: 736-750
Real Estate Broker pitches new day for dads
Real estate broker pitches new day for dads
By Beth Fitzgerald6/17/2009 -->
-->
Newark-based real estate broker Christian Benedetto Jr. today launched a new way to celebrate Father’s Day: “Take Your Father To Work Day.”
Benedetto wants today — the Wednesday before Father’s Day — to be a day for grown sons and daughters to bring Dad along with them to their offices, factories or shops to spend some quality time, while also exploring the role of work on their lives.
A month ago, Benedetto launched a Web site, DaddyOutpost.com, to spread the word, and he said more than 100 people nationwide will participate in today’s inaugural “Take Your Father To Work Day.”
“Everyone I talk to tells me they don’t spend enough time with their dad,” said Benedetto, who became a dad when Christian Benedetto III was born 14 months ago to he and his wife, Suzy Kiall Benedetto. Both are partners at Hopkins, Sampson & Brown Real Estate Advisory Service, which represents landlords and tenants in retail, office and medical real estate.
His brother, Michael, actually will be having lunch today with their father, Christian Benedetto Sr., but Chris Benedetto plans to take his dad to work with him on another day soon. He figures the event will be a success if it gets sons and daughters to make a date with their fathers.
Work and family life are major distractions from relationships with dads, Benedetto said. “One of my friends, his father lives with him and his family — and even he says he doesn’t spend enough time with his dad,” he said.
http://www.njbiz.com/article.asp?aid=78389
By Beth Fitzgerald6/17/2009 -->
-->
Newark-based real estate broker Christian Benedetto Jr. today launched a new way to celebrate Father’s Day: “Take Your Father To Work Day.”
Benedetto wants today — the Wednesday before Father’s Day — to be a day for grown sons and daughters to bring Dad along with them to their offices, factories or shops to spend some quality time, while also exploring the role of work on their lives.
A month ago, Benedetto launched a Web site, DaddyOutpost.com, to spread the word, and he said more than 100 people nationwide will participate in today’s inaugural “Take Your Father To Work Day.”
“Everyone I talk to tells me they don’t spend enough time with their dad,” said Benedetto, who became a dad when Christian Benedetto III was born 14 months ago to he and his wife, Suzy Kiall Benedetto. Both are partners at Hopkins, Sampson & Brown Real Estate Advisory Service, which represents landlords and tenants in retail, office and medical real estate.
His brother, Michael, actually will be having lunch today with their father, Christian Benedetto Sr., but Chris Benedetto plans to take his dad to work with him on another day soon. He figures the event will be a success if it gets sons and daughters to make a date with their fathers.
Work and family life are major distractions from relationships with dads, Benedetto said. “One of my friends, his father lives with him and his family — and even he says he doesn’t spend enough time with his dad,” he said.
http://www.njbiz.com/article.asp?aid=78389
Subscribe to:
Posts (Atom)
